Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

38%

3 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

5(62.5%)

Phase 3

2(25.0%)

Phase 4

1(12.5%)

8Total

N/A(5)

Phase 3(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07277998Not ApplicableNot Yet Recruiting

Alternating Triamcinolone and Platelet-Rich Plasma Therapy for Oral Submucous Fibrosis

Role: lead

NCT02742922Not ApplicableCompleted

Multicenter Study to Evaluate the Clinical and Cost-effectiveness of a Culturally Adapted Therapy (C-MAP)

Role: collaborator

NCT03379064Not ApplicableCompleted

Culturally Adapted Psychological Intervention for the Management of Irritable Bowel Syndrome (IBS)

Role: collaborator

NCT04452968Not ApplicableCompleted

Comparison of Intermittent Fasting and Caloric Deficit for Weight Loss in Women With Polycystic Ovarian Syndrome

Role: lead

NCT04302532Phase 4Completed

Coenzyme q 10 and Fertility Outcome in Women With Clomiphene Resistant PCOS

Role: lead

NCT04436172Not ApplicableCompleted

Spinal Anesthesia Facilitated Sexual Intercourse As A Treatment Option For Vaginismus

Role: lead

NCT02762097Phase 3Withdrawn

Clinical Pregnancy Rate After Removal of Unsuspected Polyps

Role: lead

NCT02758340Phase 3Completed

Failure of Vaginal Delivery After Induction

Role: lead

All 8 trials loaded